Advanced search
Publication Cover
Expert Review of Anticancer Therapy Volume 17, 2017 - Issue 4
Submit an article Journal homepage
703
Views
6
CrossRef citations to date
0
Altmetric
Review

Immunotherapeutic strategies for the treatment of renal cell carcinoma: Where will we go?

Inês Anselmo Da CostaDepartment of Urology, Eberhard Karls University, Tuebingen, GermanyView further author information
,
Steffen RauschDepartment of Urology, Eberhard Karls University, Tuebingen, GermanyView further author information
,
Stephan KruckDepartment of Urology, Eberhard Karls University, Tuebingen, GermanyView further author information
,
Tilman TodenhöferDepartment of Urology, Eberhard Karls University, Tuebingen, GermanyView further author information
,
Arnulf StenzlDepartment of Urology, Eberhard Karls University, Tuebingen, GermanyView further author information
&
Jens BedkeDepartment of Urology, Eberhard Karls University, Tuebingen, GermanyCorrespondence[email protected]
View further author information
Pages 357-368 | Received 26 Oct 2016, Accepted 03 Feb 2017, Published online: 20 Feb 2017

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Zhiqiang Yang & Fan He. (2023) An immune cell infiltration landscape classification to predict prognosis and immunotherapy effect in oral squamous cell carcinoma. Computer Methods in Biomechanics and Biomedical Engineering 0:0, pages 1-13.
Read now

Articles from other publishers (5)

Stefano Fogli, Camillo Porta, Marzia Del Re, Stefania Crucitta, Giulia Gianfilippo, Romano Danesi, Brian I. Rini & Manuela Schmidinger. (2020) Optimizing treatment of renal cell carcinoma with VEGFR-TKIs: a comparison of clinical pharmacology and drug-drug interactions of anti-angiogenic drugs. Cancer Treatment Reviews 84, pages 101966.
Crossref
Shiv Verma & Sanjay Gupta. (2019) Noncoding RNAs and Its Implication as Biomarkers in Renal Cell Carcinoma: A Systematic Analysis. annals of urologic oncology, pages 1-11.
Crossref
K. Sh. Gantsev & A. A. Khmelevskiy. (2019) Combined Use of Bevacizumab + Interferon A-2 α in the Treatement of Patients with Disseminated Kidney Cancer in Comparison with an Active Monitoring Group. Creative surgery and oncology 8:4, pages 263-267.
Crossref
Michael Daugherty, Emily Daugherty, Joseph Jacob, Oleg Shapiro, Mehdi Mollapour & Gennady Bratslavsky. (2019) Renal cell carcinoma and brain metastasis: Questioning the dogma of role for cytoreductive nephrectomy. Urologic Oncology: Seminars and Original Investigations 37:3, pages 182.e9-182.e15.
Crossref
Amar Karalli, Ramin Ghaffarpour, Rimma Axelsson, Lars Lundell, Bela Bozoki, Torkel Brismar & Ove Gustafsson. (2017) Transarterial Chemoembolization of Renal Cell Carcinoma: A Prospective Controlled Trial. Journal of Vascular and Interventional Radiology 28:12, pages 1664-1672.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.